Instructions for Author
Authors should submit their manuscripts online using the online electronic submission system ‘Scripture’ developed for this journal by Indian Orthopaedic Research Group. Please Click on links below if you are ready to Submit your article.
Already have a Username/Password for Scripture?
Need a Username/Password for Scripture?
1. About the Journal
Trauma International – Unique Journal of Trauma and Injury is a Open Access, Double-Blind peer-reviewed journal being published under the aegis of the Indian Orthopaedic Research Group (IORG), an organisation dedicated to promoting Academic research in India. Trauma International is started with an idea of a journal that will be international, intelligent, interactive and at the same time clinically relevant. The editors welcome submissions from all over the world. The stress is on latest research in the field of Trauma and Injury including emergency care, Orthopaedic and surgical care, clinical and radiographic outcomes, surgical techniques and implant design, biomechanics, and biomaterials. All aspects of case of injured will fall within the scope of the Journal.
2. Scope of the journal
Trauma International will publish papers on all aspects related to care of injured and trauma patients.
The scope of the journal is to publish research which will be of interest to original and interesting case reports that contribute significantly to Trauma Literature.
3. Editorial Process
A manuscript will be reviewed for possible publication with the understanding that it is being submitted to Trauma International alone at that point of time and it has not been published anywhere or simultaneously submitted/accepted for publication elsewhere. One of the authors should be authorized to correspond with the Journal for all matters related to the manuscript.
All manuscripts submitted are duly acknowledged. The submitted manuscripts are first checked for plagiarism using an internet search and then reviewed for suitability for publication in Trauma International. Manuscripts with high plagiarism, insufficient originality, major scientific or technical flaws and/or lack of a significant message are rejected at this stage along with manuscripts that are unlikely to be of interest to Trauma International readers. Suitable manuscripts are then subjected to a comprehensive review by the Editorial Team and/or an internal reviewer to check their adherence to reporting guidelines and robustness in rationale and methodology. If deemed necessary, manuscripts may be sent back to authors for making amendments. In such cases, only manuscripts in which satisfactory changes are made would be considered for further stages.
Manuscripts are then sent to a minimum of two independent expert reviewers to assess the scientific quality of the manuscript. The Journal follows a double-blind peer review process. The Editor-in-Chief, based on the comments and recommendations of reviewers, takes a final decision on the manuscript. The comments and suggestions (i.e., acceptance/rejection/revision) received from reviewers are conveyed to the corresponding author. If a manuscript requires revision, the author(s) is requested to provide a point-by-point response to reviewers’ comments and submit a revised version of the manuscript. This process is repeated until reviewers and editors are satisfied with the response.
Manuscripts received from the Editorial Board members are screened by the Editor-in-Chief and sent to external peer reviewers. The Editorial Board members who are authors are excluded from all publication processes and decisions of such manuscripts.
Manuscripts accepted for publication undergo substantial editing, as required, in addition to copyediting for grammar, punctuation, print style and format. All proofs are sent to the corresponding author. The corresponding author is expected to return the corrected proofs within the recommended timeframe. It may not be possible to incorporate corrections received after that period. The entire process from submission of the manuscript to final decision and the subsequent sending and receiving proofs is completed online through the website
To achieve faster and greater dissemination of knowledge and information, the Journal publishes articles online as ‘Ahead of Print’.
4. Policy against Plagiarism
The Journal follows strict anti-plagiarism policy and defines plagiarism as duplicate publication of the author’s own work, in whole or in part without proper citation, or mispresenting other’s ideas, words, and other creative expressions as one’s own. All manuscripts submitted to the journal undergo plagiarism check using an internet search. Only in cases of minor duplication or similarity with previous published work, the authors may be provided an opportunity to rectify the same; in all other cases, the manuscript is desk rejected along with the plagiarism report (please also see the Scientific Misconduct section for additional details).
5. Clinical Trial Registry
Trauma International prefers clinical trials to be registered with a clinical trial registry that allows unhindered and free online access to the public. Some of the accepted trial registers are as follows: http://www.clinicaltrials.gov/; http://www.ctri.nic.in/; http://isrctn.org/; http://www.trialregister.nl/trialreg/index.asp and http://www.umin.ac.jp/ctr. This is applicable to clinical trials that have begun enrolment of subjects in or after June 2008. From January 2021, the Journal would only consider submissions of clinical trials that have been registered, including those that commenced enrolment of subjects prior to June 2008 but retrospectively registered with a clinical trial registry that meets the Journal’s preference.
6. Authorship Criteria
Authorship credit should be based only on substantial contributions to each of the three components mentioned below:
1. Concept and design of study or acquisition of data or analysis and interpretation of data;
2. Drafting the article or revising it critically for important intellectual content; and
3. Final approval of the version to be published. Participation solely in the acquisition of funding or the collection of data does not justify authorship. General supervision of the research group is not sufficient for authorship. Each contributor should have participated sufficiently in the work to take public responsibility for appropriate portions of the content of the manuscript. The order of naming the contributors should be based on the relative contribution of the contributor towards the study and writing the manuscript. Once submitted the order cannot be changed without written consent of all the contributors.
Please note that although the Journal does not specify a maximum number of authors, if requested, the authors should provide a justification if the number of authors exceed 6 for original articles, 4 for case reports and short communications/brief reports and 2 for letters to editor.
7. Contribution Details
Contributors should provide a description of contributions made by each of them towards the manuscript. Description should be divided in following categories, as applicable: concept, design, definition of intellectual content, literature search, clinical studies, experimental studies, data acquisition, data analysis, statistical analysis, manuscript preparation, manuscript editing and manuscript review. One or more author should take responsibility for the integrity of the work from inception to publication and should be designated as the ‘guarantor’.
8. Conflicts of Interest/ Competing Interests
All authors of articles must disclose any and all conflicts of interest they may have with publication of the manuscript or an institution or product that is mentioned in the manuscript and/or is important to the outcome of the study presented. Authors should also disclose conflict of interest with products that compete with those mentioned in their manuscript. If the articles are authored by the editorial board, the conflict of interest must be clearly stated.
9. Submission of Manuscripts
10. Preparation of Manuscripts
11. Types of Manuscripts
The authors are required to use the downloadable MS Word document templates provided at the end of this page to prepare the manuscripts. The relevant reporting guideline checklist is provided in each template and must be duly followed. The authors can also choose the reporting guidelines for the specific study design from the web links provided in the table below and upload it along with the manuscript.
Reporting Guidelines for Specific Study Designs
|Initiative||Type of Study|
|CONSORT||Randomized controlled trials|
|STARD||Studies of diagnostic accuracy|
|STROBE||Observational studies in epidemiology|
|PRISMA||Systematic reviews and meta-analyses|
|MOOSE||Meta-analyses of observational studies in epidemiology|
|SQUIRE||Quality control studies|
|AGREE||Clinical Practice guidelines|
The reporting guidelines for other type of studies can be found at https://www.equator-network.org/reporting-guidelines/.
12. Protection of Patients’ Rights to Privacy
Identifying information should not be published in written descriptions, photographs, sonograms, CT scans, etc., and pedigrees unless the information is essential for scientific purposes and the patient (or parent/guardian, wherever applicable) provides informed consent for publication. Authors should remove patients’ names from figures, unless they have obtained informed consent from the patients. The journal abides by the ICMJE guidelines:
1. Authors, and not the Journal or its Publisher, need to obtain the patient consent form before submitting their work for publication consideration to TI. Authors should ensure that this patient consent form(s) are properly archived. The consent forms should not to be uploaded with the cover letter or sent through email to the Editorial or Publisher offices.
2. If the manuscript contains patient images that preclude anonymity, or a description that has obvious indication to the identity of the patient, a statement about obtaining informed patient consent should be indicated in the manuscript.
3. To protect the patient’s identity, the recognizable facial features not related to the study should be digitally blurred
4. Written informed consent is the preferred method for obtaining consent. If verbal consent is obtained, the authors must ensure that the verbal consent is recorded in the medical case record of the patient and duly signed by witness.
Sending a revised manuscript
The revised version of the manuscript should be submitted online in a manner similar to that used for submission of the manuscript for the first time. However, there is no need to submit the “First Page” or “Covering Letter” file while submitting a revised version. When submitting a revised manuscript, contributors are requested to include, the ‘referees’ remarks along with point-to-point clarification at the beginning in the revised file itself. In addition, they are expected to mark the changes as underlined or colored text in the article.
13. Scientific Misconduct
If plagiarism is detected after publication, the Journal will investigate the same, and if established, the authors’ institution and funding bodies would be notified, and the article will be retracted. To report plagiarism, please contact the Journal office, preferably through email for better documentation of correspondence.
For duplicate publication, fabricated data, undisclosed conflict of interest, plagiarism and/or other issues of publication and scientific misconduct, SJMMS follows the guidance produced by Committee on Publication Ethics (COPE), World Association of Medical Editors (WAME) and International Committee of Medical Journal Editors (ICMJE).
TI endeavors to avoid all possible misconduct. All manuscripts are checked for plagiarism using iThenticate. If the Editor or a reviewer is concerned that some aspect of a submitted article may constitute a misconduct in research, publication or professional behavior, the Journal communicates the same to the author(s) and seeks clarification. However, if the concerns are not satisfactorily resolved by discussion with the author(s), the Journal may report the same to appropriate authorities such as their institutions and, for duplicate publication, the journal in which the previous publication had appeared.
The Journal also encourages its readers to report any published article in which they suspect misconduct through e-mail or letter. Anonymity of the complainant would be maintained at all times.
14. Manuscript submission, processing and publication charges
The journal does not charge for submission, Article Publishing charges: 3500 INR or 150 USD (for international articles).
The entire contents of the Trauma International are protected under India and international copyrights. However, the Journal grants to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, perform and display the work publicly and to make and distribute derivative works in any digital medium for any reasonable non-commercial purpose, subject to proper attribution of authorship and ownership of the rights. The journal uses a recent Creative Commons License.
Acceptance or rejection
Manuscripts are judged on the interest and importance of the topic, intellectual and scientific strength, clarity of presentation and relevance to Trauma International readers.
16. Complaints and Appeals
This procedure applies to complaints about the publishing policies, procedures and/or actions of the Trauma Internationals’ Editorial staff. This complaint must relate to content or a procedure that was the responsibility of the Trauma International or its Editor.
If the authors strongly believe that their manuscript was wrongly rejected, they can register an appeal with the Journal by emailing detailed explanation to email@example.com. The appeals will be acknowledged by the Editorial Office and will be investigated in an unbiased manner. While under appeal, the said manuscript should not be submitted to other journals. The final decision rests with the Editor-in-Chief, and second appeals are not considered.
The Journal only accepts complaints through the above-mentioned e-mail, as this provides a reliable trail. All complaints are acknowledged at the earliest. The complaint would be followed-up in an unbiased manner and be handled by the person to whom they are made, if possible. The Journal aims to resolve any complaint raised within 2–4 weeks; however, if that is not possible, an interim response would be provided until the complaint is resolved.
Instructions for Manuscript Preparation
Manuscripts should be written only in English. Authors whose native language is not English should seek the assistance of a colleague who is a native English speaker and familiar with the field of the work. Authors are advised to follow the recommendations in the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication” proposed by the International Committee of Medical Journal Editors (www.icmje.org). Manuscripts must be typed double-spaced with wide margins on A4 paper. The manuscript parts should be in the following order, with each section beginning on a new page: Title page, Abstract, Text, Acknowledgements, References, Tables, figure with legends. Number all lines in a continuous manner and number all pages in the bottom right corner beginning with the title page. For reports on randomized control studies, authors should refer to the CONSORT statement (www.consort-statement.org). Standard abbreviations and SI units should be used. Define abbreviations at first appearance in the text, figure legends, and tables, and avoid their use in the title and abstract. Use generic names of drugs and chemicals.
All manuscripts are to be submitted via the Journal submission software ‘Scripture’ on the website www.traumainternationalonline.co.in. Any other query regarding article formatting for submission process can also be mailed to firstname.lastname@example.org
Scope of the Journal :
Trauma International will publish papers on all aspects related to the care of injured and trauma patients.
Submission Formats/Categories :
Trauma International accepts the following formats of articles
- Case Study /Series
- Case Image
- Technical Note
- Master Class
- Video Technique
- Surgical Tips and tricks
- Burning Questions
- Case Approach
- Case Reports
- Clinical Perspective
- Original articles
- Letter to Editor
- Reviews, meta-analysis, systematic reviews
- Letter to Experts
Description of various Categories is provided below
A clinical overview of a common topic with the aim to share with readers the recent update and current state of affairs.
Invited article from an Expert in the Field specially focusing on their area of Research or Interest.
Academicians and Researchers across the world will get a chance to feature in our interview section and share their views.
Master Class :
In this feature we will invite a ‘Master’ to demonstrate videos or pictorial demonstrations of surgical techniques or concepts.
An innovative concept or an Idea that provides a new perspective. This needs to send directly to editorial email and after editorial review it will be send for peer review. 1000 words article describing the new concept, implant, protocol or surgical modification should be accompanied with a note of how this will be clinically relevant.
Burning Questions :
Opinion/Counter opinions from experts or group of experts on selected topics.
Original Articles :
Include case series, comparative trials, epidemiological studies and RCT’s.
Case Reports :
Have been detailed below and all the remaining formats follow similar guidelines as case reports.
Case Image :
Is description of a single Image which has an unique learning point.
Technical Note and Video Technique :
Detailed description of a new technique or improvisation of an old technique.
Surgical Tips :
Small surgical tips and pearls are invited for this section. Pictures are essential and video will be preferable.
Case Study :
This new format combines the level V evidence with Clinical Decision Making (CDM). It focuses on getting the thought process of the treating surgeon when dealing with a complex/complicated case.
Case Approach :
This is a new but invited only section. We will invite an expert to describe to his approach to a particular case scenario with literature and rationale behind the approach.
Clinical Perspective :
This special section will publish specific learning points or experiences which the authors can share with the readers. The only essential point is that this perspective should be clinically relevant and rationally acceptable. This need not be with details of management or follow up of the case. The idea is to provide a platform for publication of these important and clinically relevant learning points. A single page write up of less than 1000 words will be accepted.
Letter to Editor :
On articles in Trauma International. Letters should be typed double-spaced and limited to 1000 words. A copy of the letter will be sent to the previous article’s author(s) to invite a response.
Letter to Experts :
Trauma International will soon be creating an Expert panel of surgeons. Readers of TI can ask queries regarding complicated cases to our Experts. These queries will be answered by experts and the Research Group will add literature review to this expert opinion and article will be peer reviewed and published in 15 days.
Pictorial articles which will be an easy read with most important message highlight.
Copyright Agreement and Submission letter :
A copyright agreement signed by all authors and containing the following paragraph must accompany each manuscript: “The undersigned author(s) transfer(s) all copyright ownership of the article entitled to the Trauma International in the event the work is published. The undersigned author(s) warrant(s) that the article is original, is not under consideration by another journal, and has not been published previously. We sign for and accept responsibility for releasing this material.”
In case a paper has previously been presented or published as a poster in a national or international conference, the author(s) must make a full disclosure to the editor about it. Such papers are still eligible for publication in the journal provided the author(s) disclose this during their submission.
Conflict-of-interest Statement :
All authors are expected to disclose any commercial affiliations as well as consultancies, stock ownership, or patent-licensing arrangements that could be considered to pose a conflict of interest regarding the submitted article. A conflict-of-interest statement will be forwarded to the corresponding author for signature upon acceptance of the manuscript. The signature of all authors is required. No article will be published until return of the completed form to the journal office.
Conflict of Interest forms are according to Guidelines by International Committee of Medical Journal Editors and Each Authors details have to be filled separately and submitted with the manuscript. Plagiarism is not permitted and Journal will check every article for plagiarism using iThenticate and Internet search.
Ahead of Print Policy:
Articles published online under the Ahead of Print section are considered published and can be cited and quoted using the DOI as the reference source in the upcoming issue.
Article Charges :
Since the Journal is Open access, the cost of publication is shared by the author and the Journal equally. For every submission that is accepted for publication, the article processing charges will be 3500 INR (for papers from India) and 150 USD (for foreign articles). Open access will allow us to make your article free to access and download by everyone and will invite better citation and wide outreach. There are no charges for submitting the manuscript or for peer review and decision on the manuscript. Authors will usually receive a decision on their manuscript within 8-12 weeks.
Article submission Charges : None
Article Publishing charges: 3500 INR or 150 $ (for international article). The publishing charges has to paid only on acceptance of the article.
Editors Office :
Dr Ashok Shyam
A-403, Manthan Apts, Shreesh CHS, Hajuri Road, Thane [W]
Maharashtra, India. Pin 400604
Contact Trauma International: